Dyrness Albert D. 4
4 · Sonnet BioTherapeutics Holdings, Inc. · Filed May 31, 2023
Insider Transaction Report
Form 4
Dyrness Albert D.
Director
Transactions
- Purchase
Common Stock
2023-05-30$0.47/sh+23,255$10,883→ 28,962 total
Footnotes (1)
- [F1]Includes unvested RSUs.